These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 17702567

  • 1. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
    Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, Hammerlid E, Bottomley A, Van Cutsem E, Blazeby JM, European Organisation for Research Treatment of Cancer Gastrointestinal and Quality of Life Groups.
    Eur J Cancer; 2007 Sep; 43(14):2066-73. PubMed ID: 17702567
    [Abstract] [Full Text] [Related]

  • 2. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D'haese S, Coens C, European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups.
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [Abstract] [Full Text] [Related]

  • 3. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, García-Hubard G, Rojas-Castillo E, Alvarado-Aguilar S, Carrillo JF, Blazeby JM, Aiello-Crocifoglio V.
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [Abstract] [Full Text] [Related]

  • 4. Validation of the polish version of the eortc QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer.
    Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K.
    J Psychosoc Oncol; 2013 Jan; 31(2):191-203. PubMed ID: 23514254
    [Abstract] [Full Text] [Related]

  • 5. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU.
    Oncology; 2008 Jan; 74 Suppl 1():7-12. PubMed ID: 18758191
    [Abstract] [Full Text] [Related]

  • 6. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group.
    Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652
    [Abstract] [Full Text] [Related]

  • 7. Reference values of oesophago-gastric symptoms (EORTC QLQ-OG25) in a population-based setting.
    van der Schaaf M, Derogar M, Lagergren P.
    Eur J Cancer; 2012 Jul 15; 48(11):1602-7. PubMed ID: 22119353
    [Abstract] [Full Text] [Related]

  • 8. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers.
    Oñate-Ocaña LF, Velázquez-Monroy N, Vázquez L, Espinosa-Mireles-de-Villafranca P, Núñez-Rosas E, Ovando-Lezama M, Vilar-Compte D, García-Hubard G, Carrillo JF, Blazeby JM, Aiello-Crocifoglio V.
    Psychooncology; 2012 Jul 15; 21(7):745-53. PubMed ID: 21538681
    [Abstract] [Full Text] [Related]

  • 9. Psychometric analysis of a Persian version of the European Organization for Research and Treatment of Cancer OG25 Quality of Life Questionnaire in oesophagogastric cancer patients.
    Hesari AE, Lari MA, Shandiz FH.
    Asian Pac J Cancer Prev; 2014 Jul 15; 15(6):2739-45. PubMed ID: 24761894
    [Abstract] [Full Text] [Related]

  • 10. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A, EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups.
    Eur J Cancer; 2010 Apr 15; 46(6):1033-40. PubMed ID: 20181476
    [Abstract] [Full Text] [Related]

  • 11. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jul 15; 43(11):1670-8. PubMed ID: 17574838
    [Abstract] [Full Text] [Related]

  • 12. Validity and Reliability of the Amharic Version of EORTC QLQ-OG25 Among Esophagogastric Cancer Patients in Ethiopia.
    Abebe LG, Wondimagegnehu A, Kantelhardt EJ, Addissie A.
    Cancer Rep (Hoboken); 2024 Oct 15; 7(10):e70035. PubMed ID: 39423304
    [Abstract] [Full Text] [Related]

  • 13. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients.
    Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB.
    Eur J Cancer; 2012 Sep 15; 48(14):2203-11. PubMed ID: 22572480
    [Abstract] [Full Text] [Related]

  • 14. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.
    van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK.
    Eur J Cancer; 2008 Nov 15; 44(16):2418-24. PubMed ID: 18774706
    [Abstract] [Full Text] [Related]

  • 15. [Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module].
    Morita S, Shimozuma K, Sato A, Nakamachi M, Blazeby J, West K, Fukuhara S, Sakamoto J.
    Gan To Kagaku Ryoho; 2004 Aug 15; 31(8):1195-9. PubMed ID: 15332542
    [Abstract] [Full Text] [Related]

  • 16. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
    Morita S, Kaptein AA, Oba K, Sakamoto J.
    Psychooncology; 2008 May 15; 17(5):474-9. PubMed ID: 17847126
    [Abstract] [Full Text] [Related]

  • 17. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group.
    Eur J Cancer; 2004 Nov 15; 40(16):2439-44. PubMed ID: 15519517
    [Abstract] [Full Text] [Related]

  • 18. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N, Ntinoulis K, Niakas D.
    Eur J Cancer Care (Engl); 2011 May 15; 20(3):354-61. PubMed ID: 20345453
    [Abstract] [Full Text] [Related]

  • 19. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H, Rajapaksa LC, Greimel ER.
    Psychooncology; 2008 Oct 15; 17(10):1053-7. PubMed ID: 18203241
    [Abstract] [Full Text] [Related]

  • 20. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
    Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M, Sezer O, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jan 15; 43(1):87-94. PubMed ID: 17081744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.